Year-End Review

As we close the year, we extend our appreciation for the confidence that has enabled our continued international growth. Our comprehensive portfolio of diagnostic solutions is now deployed in nearly 20 countries worldwide, including key markets such as Germany, Turkey, Vietnam, Romania, Serbia and many more.
Our growth is a direct reflection of your success. We remain committed to delivering not only high-quality allergy kits and reagents, but a complete suite of solutions to support precise and reliable laboratory diagnostics. The full portfolio is available here.

Looking Ahead to 2026: We are planning significant strategic expansion into new countries throughout Europe, Africa and Asia, aiming to further solidify our international footprint. Join the Astra Biotech international distribution network!